Tissue Diagnostics Market | Trends & Forecast | 2018-2025

1. Presents a Research Report on Tissue Diagnostics Market Opportunities & Gaps in the Tissue Diagnostics Market: By Product (Consumables, Instruments), By Technology (Immunohistochemistry, in Situ Hybridization, Digital Pathology & Others), By Condition (Breast Cancer, Gastric Cancer, and Lymphoma), By End User (Hospital, Clinics, Pharmaceutical R&D, and CRO), By Region (APAC, Western Europe, North America, LATAM and ROW) sales@stratviewresearch.com +1-313-307-4176 www.stratviewresearch.com Market Reports Advisory & Consulting Sourcing Intelligence

2. Tissue Diagnostics Market: Highlights • The Tissue Diagnostics Market offers a healthy growth opportunity in the entire ecosystem in the forecast period 2018 - 2025. • As we approach 2019, liquid biopsy is becoming a reality, for confirmatory diagnosis often repeated biopsies are needed to study the changing tumor and therefore, present a huge challenge to the patient. • The process is risk prone, painful as well adds cost to the procedure. • It is expected in about two years, liquid biopsy will become an adjunct to tissue biopsy. • This technology has proven to be much more effective and detects worsening of a disease condition even before a CT scan, saving unnecessary medical expenses. • The future of clinical diagnostics is expected to be far more connected, companies such as GE Healthcare and Roche are collaborating (January 2018) develop integrated digital diagnostics platform to improve oncology and critical care treatment. The Burning Questions This Report Will Answer: Will liquid biopsy become an adjunct to tissue biopsy by 2020? What will happen to the existing players in the market? Is there a Kodak Moment Awaited beyond 2020? What are the recent collaborations and JV in this segment which are expected to change the course of diagnosis? Who are the game changers in this market and where?

3. Key Companies Analyzed • Key Companies: • Roche (Switzerland) • Danaher (US) • ThermoFisher Scientific (US) • Abbott (US) • Cell Signaling Technology (US) • Agilent Technologies (US) • Merck (Germany) • Tissue Gnostics (Austria) • Sakura Finetek Japan (Japan) • Abcam(UK) • BD (US) • QIAGEN (Netherlands) • Sienna Cancer Diagnostics (Australia) • Royal Philips (Netherlands) • A. Menarini Diagnostics (Italy) • Enzo Life Sciences (US)

4. Market Segmentation • The global clinical diagnostics market - tissue is segmented into the following categories: • By Product Type • Consumables • Antibodies • Kits • Reagents • Probes • Instruments • Slide Staining System (Conventional) • Scanners • Tissue Processing Systems • Other Methods • By Technology • Immunochemistry (IHC) • In Situ Hybridization (ISH) • Digital Pathology • Special Staining

5. Market Segmentation • The global clinical diagnostics market - tissue is segmented into the following categories: • By Condition • Breast Cancer • Gastric Cancer • Lymphoma • Prostate Cancer • Non-Small Cell Lung Cancer (NSCLC) • Other Diseases • By End User • Hospitals, • Pharma R&D • Clinics • CRO • Others • By Region • North America (Country Analysis: the USA, Canada) • Western Europe (Country Analysis: Germany, France, the UK) • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific) • Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others) • Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others)

6. Report Features • This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights on the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report: • Market structure: Overview, industry life cycle analysis, supply chain analysis. • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis. • Market trend and forecast analysis. • Market segment trend and forecast. • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc. • Attractive market segments and associated growth opportunities. • Emerging trends. • Strategic growth opportunities for the existing and new players. • Key success factors.

7. Data Analysis (Top Down and Bottom Up Approach) Research Methodology Data Triangulation (Data Evaluation and Multiple Data Triangulation) Final Deliverables (Final Report with All Findings) Stratview Research follows a rigorous methodology with high emphasis on primary research and multiple ways of data triangulation. We conduct primary research across the value chain to provide 360 degree view of the market. • Secondary Research • Stratview Research Internal Knowledgebase Primary Research • Annual Reports / Fact Book • Company Websites • Magazines / Publications • Press Releases & Journals • Industry News • Association Articles • Government Documents • Social Media • Others • Robust database across value chain • In-house industry veterans as advisors • Project based subject matter experts • Industry Players • Industry Experts • Suppliers • Customers • Associations • Government Institutions • Others

8. About Stratview Research Stratview Research is a global market intelligence firm providing high quality syndicated reports, custom research and consulting services. Our Services Why Us? High Customer Delight Rich Industry Experience Robust Methodology Effective Business Decisions

9. Contact Us for More Information and Sample Pages Ask for Sample Pages here: https://www.stratviewresearch.com/406/tissue-diagnostics-market-tissue.html Email us at: sales@stratviewrsearch.com Call Us: +1-313-307-4176